HLYK — HealthLynked Income Statement
0.000.00%
- $6.81m
- $7.37m
- $3.01m
- 31
- 24
- 11
- 10
Annual income statement for HealthLynked, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.13 | 6.5 | 5.86 | 5.72 | 3.01 |
Cost of Revenue | |||||
Gross Profit | 3.84 | 3.54 | 2.83 | 3.37 | 1.36 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11.3 | 16.8 | 14.5 | 10 | 7.87 |
Operating Profit | -5.13 | -10.3 | -8.66 | -4.3 | -4.86 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.76 | -10.7 | -8.07 | -3.61 | -6.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.76 | -10.7 | -8.07 | -3.61 | -6.13 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -5.76 | -10.4 | -8.82 | -1.01 | -6.13 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.2 | -10.8 | -9.17 | -1.01 | -6.13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.029 | -0.027 | -0.023 | -0.012 | -0.019 |